How NOT to Solicit Adverse Medical Event Reports
My Twitter and real-life pal Fabio Gratton (@skypen) -- Co-founder & Chief Innovation Officer of Ignite Health -- sent out this tweet today:
New Web Site Invites Patients To Report on Adverse...
Social Media and the Future of Adverse Event Reporting
I am speaking tomorrow at the World Drug Safety Congress in Washington, DC. The title of my presentation is "Social Media and the Future of Adverse Event Reporting." You can view...
Pharma’s ObamaCare Math: It All Adds Up, But…
Drug companies are already claiming a loss of income due to costs related to the new U.S. health-care overhaul (aka, "ObamaCare"). First, Lilly claimed costs associated with higher rebates to the...
Pharma “Social Networks”: Close But No Cigar Award
If you are a regular reader of Pharma Marketing Blog, you know that I generally do not like awards that are given to pharmaceutical marketers by trade publications. Such awards are...
Voltaren “Adherence Email” Gets FDA Warning Letter: Is It Justified?
As of April 15, 2010, FDA's Division of Drug Marketing, Advertising and Communications (DDMAC) sent out 5 "notice of violation" (aka "warning") letters to drug companies regarding various promotional pieces. One...
Pre-Screening, Post-Screening, or No Screening at All – What’s the Best Moderation Practice for...
As more and more pharmaceutical companies launch social networking platforms associated with their brands, some will allow users (consumers, patients, physicians, and the anonymous rabble) to post comments as part of...
If Patients Know Best, then Patient Social Networks Can Help Capture and Report AEs
A recent article published in the New York Times caught my attention. The article -- "In Reporting Symptoms, Don’t Patients Know Best?" (find it here) -- suggested that doctors tend to...
New Omnaris TV Ad is Less Freudian, Still Amateurish
There are plenty of negative comments on various Internet forums about the first generation of Omnaris TV commercials, which began to air last year. These ads featured military-style "Orkin" men sticking...
The iPad as a Pharma Marketing Platform
"DTC marketers can't afford the luxury of waiting to see how many people purchase an iPad they have to start experimenting with app development and marketing NOW," says Rich Meyer over...
An Analysis of DDMAC Warning Letters Regarding Risk Information in Broadcast Drug Ads
The FDA Amendments Act (FDAAA), which was signed into law in 2007, requires that the FDA issue new regulations regarding the presentation of risk information in broadcast (TV and radio) drug...
